Switch theme
Sign up to access all valuation multiples
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
2000
1.1K+
LTM Revenue $589M
LTM EBITDA $171M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nutex Health has a last 12-month revenue (LTM) of $589M and a last 12-month EBITDA of $171M.
In the most recent fiscal year, Nutex Health achieved revenue of $480M and an EBITDA of $149M.
Nutex Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nutex Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $589M | XXX | $480M | XXX | XXX | XXX |
| Gross Profit | $589M | XXX | $196M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 41% | XXX | XXX | XXX |
| EBITDA | $171M | XXX | $149M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 31% | XXX | XXX | XXX |
| EBIT | $156M | XXX | $138M | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | 29% | XXX | XXX | XXX |
| Net Profit | $44.2M | XXX | $52.2M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nutex Health's stock price is $168.
Nutex Health has current market cap of $933M, and EV of $1.2B.
See Nutex Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $933M | XXX | XXX | XXX | XXX | $7.90 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nutex Health has market cap of $933M and EV of $1.2B.
Nutex Health's trades at 2.5x EV/Revenue multiple, and 8.0x EV/EBITDA.
Equity research analysts estimate Nutex Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nutex Health has a P/E ratio of 21.1x.
See valuation multiples for Nutex Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $933M | XXX | $933M | XXX | XXX | XXX |
| EV (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 6.9x | XXX | 8.0x | XXX | XXX | XXX |
| EV/EBIT | 7.6x | XXX | 8.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.1x | XXX | 17.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 57.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNutex Health's last 12 month revenue growth is 28%
Nutex Health's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Nutex Health's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nutex Health's rule of X is 100% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nutex Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 28% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 31% | XXX | XXX | XXX |
| EBITDA Growth | 45% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 59% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 100% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nutex Health acquired XXX companies to date.
Last acquisition by Nutex Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Nutex Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nutex Health founded? | Nutex Health was founded in 2000. |
| Where is Nutex Health headquartered? | Nutex Health is headquartered in United States of America. |
| How many employees does Nutex Health have? | As of today, Nutex Health has 1.1K+ employees. |
| Who is the CEO of Nutex Health? | Nutex Health's CEO is Dr. Thomas T. Vo, M.B.A.,M.D.. |
| Is Nutex Health publicy listed? | Yes, Nutex Health is a public company listed on NAS. |
| What is the stock symbol of Nutex Health? | Nutex Health trades under NUTX ticker. |
| When did Nutex Health go public? | Nutex Health went public in 2022. |
| Who are competitors of Nutex Health? | Similar companies to Nutex Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Nutex Health? | Nutex Health's current market cap is $933M |
| What is the current revenue of Nutex Health? | Nutex Health's last 12 months revenue is $589M. |
| What is the current revenue growth of Nutex Health? | Nutex Health revenue growth (NTM/LTM) is 28%. |
| What is the current EV/Revenue multiple of Nutex Health? | Current revenue multiple of Nutex Health is 2.0x. |
| Is Nutex Health profitable? | Yes, Nutex Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nutex Health? | Nutex Health's last 12 months EBITDA is $171M. |
| What is Nutex Health's EBITDA margin? | Nutex Health's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Nutex Health? | Current EBITDA multiple of Nutex Health is 6.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
